May 28 (Bloomberg) -- Sigma Pharmaceuticals Ltd. institutional shareholders want Aspen Pharmacare Holdings Ltd. to raise its takeover offer to at least 80 Australian cents a share, the Australian Financial Review reported, without saying where it got the information or naming the investors. The shareholders have asked Sigmas board to reject the current A$0.60 a share bid, according to the newspaper.